MicroRNA-186 Suppresses Cell Proliferation and Metastasis Through Targeting Sentrin-Specific Protease 1 in Renal Cell Carcinoma
Authors:
Open Access
- 5 March 2018
- journal article
- research article
- Published by Tech Science Press in Oncology Research
- Vol. 26 (2) , 249-259
Abstract
Recent evidence suggests that dysregulation of microRNAs is associated with the development of multiple malignancies. miR-186 has been reported as a critical cancer regulator in several types of cancers. However, its functional significance and molecular mechanism underlying renal cell carcinoma (RCC) remain unknown. In this study, our results showed that miR-186 expression was dramatically downregulated in RCC tissues and cell lines compared to that in adjacent normal tissues and cell lines. Overexpression of miR-186 significantly inhibited cell growth, colony formation, and cell invasion; caused cell cycle arrest at the G0/G1 phase; and induced cell apoptosis as detected by MTT, colony formation, Transwell assay, and flow cytometry assays in RCC cells. In addition, inhibition of miR-186 expression promoted RCC cell proliferation, invasion, and cell cycle progression and reduced apoptosis. Bioinformatics analysis and luciferase reporter assay confirmed that the 3′-UTR of sentrin-specific protease 1 (SENP1) was a direct target of miR-186. A remarkably reverse correlation was observed between miR-186 and SENP1 mRNA in RCC tissues. Furthermore, immunohistochemical staining revealed that SENP1 was positively expressed in RCC specimens. Restoration of SENP1 expression could partially abrogate the inhibitory effect of miR-186 overexpression on RCC cell proliferation through activating NF-κB signaling and its downstream proteins. These data demonstrated that miR-186 acted as a novel tumor suppressor and potential therapeutic biomarker in the progression of RCC by directly targeting SENP1.Keywords
This publication has 30 references indexed in Scilit:
- miR-935 Promotes Liver Cancer Cell Proliferation and Migration by Targeting SOX7Oncology Research, 2017
- MicroRNAs: A Puzzling Tool in Cancer Diagnostics and TherapyAnticancer Research, 2016
- miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3β in human renal cell carcinomaTumor Biology, 2014
- Current management and future perspectives of metastatic renal cell carcinomaInternational Journal of Urology, 2014
- MicroRNA-21 is Overexpressed in Renal Cell CarcinomaThe International Journal of Biological Markers, 2013
- Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)International Journal of Oncology, 2012
- The Epidemiology of Renal Cell CarcinomaEuropean Urology, 2011
- Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancersMedicinal Research Reviews, 2010
- Targeted therapy for renal cell cancer: current perspectives.2010
- Lifestyle Factors, Exposures, Genetic Susceptibility, and Renal Cell Cancer Risk: A ReviewCancer Investigation, 2005